Quantitative drug safety and benefit risk evaluation

Quantitative drug safety and benefit risk evaluation
Quantitative drug safety and benefit risk evaluation
Produseres på bestilling
ISBN/Varenr
9781032191119
Inngår i din bokpakke

Omtale

This book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.
Vis hele omtalen… Vis mindre

Produktinformasjon

  • ISBN/Varenr: 9781032191119
  • Utgivelsesdato: 29.01.2024
  • Utgivelsesår: 2024
  • Forlag: Taylor and Francis
  • Innbinding: Heftet
  • Serie: Chapman & Hall/CRC Biostatistics Series
  • Språk: Engelsk
  • Aldersgrense: 0
  • Opplag: 0
  • Utgave: 0
  • Illustrert: Nei
  • Sider: 382